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Human immunodeﬁciency virus gene expression and replication are regulated at several levels.
Incompletely spliced viral RNAs and full-length genomic RNA contain the RRE element and are bound
by the viral trans-acting protein Rev to be transported out of the nucleus. Previously we found that
the nuclear matrix protein MATR3 was a cofactor of Rev-mediated RNA export. Here we show that
the pleiotropic protein PSF binds viral RNA and is associated with MATR3. PSF is involved in the
maintenance of a pool of RNA available for Rev activity. However, while Rev and PSF bind the viral pre-
mRNA at the site of viral transcription, MATR3 interacts at a subsequent step. We propose that PSF and
MATR3 deﬁne a novel pathway for RRE-containing HIV-1 RNAs that is hijacked by the viral Rev protein.
& 2012 Elsevier Inc. All rights reserved.Introduction
Human immunodeﬁciency virus type 1 (HIV-1) gene expres-
sion and replication are regulated at the transcriptional and post-
transcriptional level. The generation of infectious viral progeny
requires the synthesis and export to the cytoplasm of several fully
spliced subgenomic mRNAs encoding for regulatory factors that
include the Tat transactivator and Rev (Greene and Peterlin,
2002). Rev promotes the expression of Gag, Pol and Env incom-
pletely spliced viral RNAs and full-length genomic RNAs (Malim
et al., 1989; Sodroski et al., 1986) reviewed in: Kula and Marcello
(2012), Pollard and Malim (1998), Yedavalli and Jeang (2011b).
Rev promotes the export of this class of RNAs from the nucleus
through the association with an RNA element called the Rev
response element (RRE) that is present in the env gene (Chang and
Sharp, 1989; Kjems et al., 1991; Zapp and Green, 1989). HIV-1
exploits a variety of mechanisms to make sure that all required
RNAs are balanced for an efﬁcient life cycle (Purcell and Martin,
1993; Schwartz et al., 1990). Sub-optimal splice acceptor
sequences and the activity of splicing regulators reduce HIV-1
pre-mRNA splicing rates (Amendt et al., 1994, 1995; Caputi et al.,
1999; Dyhr-Mikkelsen and Kjems, 1995; O’Reilly et al., 1995; Si
et al., 1997; Staffa and Cochrane, 1994, 1995; Tange et al., 2001).ll rights reserved.This mechanism is believed to permit the production of both
fully spliced mRNAs as well as RRE-containing RNAs. HIV-1
also encodes for regulatory sequences called the instability (INS)
sequences (Cochrane et al., 1991; Maldarelli et al., 1991;
Nasioulas et al., 1994; Schneider et al., 1997; Schwartz et al.,
1992). One possible role for these elements is to ensure that
incompletely spliced pre-mRNAs are not simply degraded in the
nucleus prior to export to the cytoplasm by preserving the RNA in
nuclear sub-compartments (Berthold and Maldarelli, 1996; Chang
and Sharp, 1989; Mikaelian et al., 1996). Hence, a combination of
cis-acting RNA sequences with a trans-acting viral protein (Rev)
together with host factors concur to regulate HIV-1 gene expres-
sion and replication.
The molecular details of Rev binding to RRE as well as the
mechanism of Rev-mediated RNA export by Exportin 1 (CRM1)
have been described in detail (Daugherty et al., 2010; Fornerod
et al., 1997; Kjems et al., 1991; Malim and Cullen, 1991).
However, much less is known of the nuclear steps that occur
between pre-mRNA biogenesis, Rev recognition and nuclear
export. To address this issue we have recently initiated an
unbiased program of discovery of nuclear factors that associated
with HIV-1 RNA (Kula et al., 2011). Among them Matrin 3
(MATR3) was found to be speciﬁcally associated with the viral
RNA, as conﬁrmed also by other groups (Naji et al., 2011;
Yedavalli and Jeang, 2011a). MATR3 had no effect on transcription
from the HIV-1 LTR but promoted the Rev-dependent cytoplasmic
accumulation and consequent translation of RRE-containing
A. Kula et al. / Virology 435 (2013) 329–340330unspliced RNAs (Kula et al., 2011; Yedavalli and Jeang, 2011a).
MATR3 is a RNA binding protein and a component of the inner
nuclear matrix (Belgrader et al., 1991; Hibino et al., 2006;
Nakayasu and Berezney, 1991; Zeitz et al., 2009). Together with
the cellular protein polypyrimidine tract-binding protein asso-
ciated binding factor PSF (also known as splicing factor Proline-
Glutamine Rich, SFPQ), MATR3 has been implicated in the nuclear
retention of hyperedited mRNA (Prasanth et al., 2005; Zhang and
Carmichael, 2001). PSF is a multifunctional nuclear protein that
has been involved in a variety of processes in addition to nuclear
retention of hyperedited RNA including splicing and transcription
(Emili et al., 2002; Kaneko et al., 2007; Shav-Tal and Zipori, 2002).
PSF has also been shown to bind speciﬁcally to HIV-1 INS
elements (Zolotukhin et al., 2003). PSF was also found associatedFig. 1. PSF binds HIV-1 RNA and acts at the post-transcriptional level. (A) Pulldown of
U2OS_HIVexo, U2OS_HIVintro or U2OS_CMV24xMS2 expressing Flag-MS2nls and Tat w
performed to detect the RNA-bound endogenous PSF (IP). Immunoblots for the whole ce
leads to a decrease of Gag expression. HeLa cells were transfected with the siRNA targe
were co-transfected with pNL4.3R-E-luc and harvested 24 h later for immunobloting
luciferase activity. HeLa cells were transfected with the indicated siRNAs. After 48 h s
pNL4.3R-E-luc HIV molecular clone and harvested 24 h later for luciferase assays. Relativ
The results of three independent experiments are shown 7SD.with HIV-1 RNA in the nucleus but it’s role in HIV-1 gene
expression remained unknown (Kula et al., 2011).
In this work we investigated the role of PSF in Rev-mediated
RNA export and its relationship with MATR3. We found that PSF is
not involved in LTR-mediated transcription but is required for Rev
activity independent of A to I hyperediting of HIV-1 RNA. PSF and
MATR3 interacted at the protein level while their interaction with Rev
occurred only through RNA. PSF and Rev associated with nascent
pre-mRNA at the HIV-1 transcription site while MATR3 bound viral
unspliced RNA in the insoluble nuclear matrix. Since PSF was shown
to bind the INS elements (Zolotukhin et al., 2003) and MATR3 was
shown to promote Rev-mediated export of unspliced RNA (Kula et al.,
2011), we propose that HIV-1 unspliced RRE-containing HIV-1 RNAs
are committed to MATR3/Rev mediated export by PSF.HIV-1 RNA and endogenous PSF. Whole cell extracts from mock cells (U2OS_wt),
ere immunoprecipitated with anti-ﬂag antibody. Immunoblot analysis was then
ll extracts against PSF and ﬂag-MS2nls (input) are also shown. (B) PSF knockdown
ting PSF (siPSF) or with a control siRNA (siCTRL). After 48 h siRNA-transfected cells
. Tubulin is the protein loading control. (C) PSF knockdown does not affect the
iRNA-transfected cells were co-transfected with pCMV-Renilla together with the
e Luc/RL expression was normalized to protein levels measured by Bradford assay.
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Identiﬁcation of PSF as a factor required for post-transcriptional
expression of gag mRNA
Previously, to identify cellular HIV-1 RNA binding factors, we
developed a novel proteomic approach based on the MS2 tagging
system (Maiuri et al., 2011a). Brieﬂy, we used stable cells lines with
an integrated viral vector expressing viral RNA tagged with MS2-
binding sites and we afﬁnity puriﬁed RNA and associated proteins
by ﬂag-MS2 pull down (Kula et al., 2011). Mass spectrometry
analysis revealed several cellular factors as potential viral RNA
regulators. In this screen we identiﬁed both MATR3 and PSF.
We and others identiﬁed MATR3 as a nuclear factor that stimulates
the Rev-dependent cytoplasmic accumulation and translation ofFig. 2. PSF knockdown affects Rev activity on unspliced HIV-1 RNA. (A) Knockdown of P
with a control siRNA (siCTRL). After 48 h cells were co-transfected to express vHY-IRES-
the efﬁciency of PSF knockdown. Tubulin is the protein loading control. (B) RT-PCR of sp
(US) HIV-1 RNAs (lines 1–4, upper panel) were detected simultaneously on an Ethidium-
cells treated with siRNAs as described above (A). RT-PCR ampliﬁcation of an unrelated R
are shown to demonstrate lack of DNA contamination (lines 5–8). Water (mock) use
unspliced HIV-1 RNA levels modulated by MATR3. Unspliced (US) viral RNA expression i
PCR and data normalized to b-mRNA expression. Data are presented as fold change, wh
three independent experiments are shown 7SD. The inhibition was signiﬁcant (po0
protein extracts from siRNA-treated 293 T cells expressing vHY-IRES-TK, Tat and Rev-EG
IRES-TK vector. Tubulin is the protein loading control.RRE-containing unspliced RNAs (Kula et al., 2011; Yedavalli, 2011).
Since PSF binds MATR3 and HIV-1 RNA we wished to explore its
activity in HIV-1 gene expression.
To conﬁrm that PSF speciﬁcally co-immunoprecipitates with
viral RNA we transfected the U2OS_HIVexo and U2OS_HIVintro
stable cell lines carrying the MS2-tagged HIV construct with ﬂag-
MS2nls and Tat, the viral trans-activator that allows transcription
of the viral genes (Marcello et al., 2001). As negative controls we
used U2OS wild type and U2OS carrying an integrated CMV-
driven construct expressing RNA with the same number of MS2
repeats after an unrelated intron (U2OS_CMV24MS2). Cells
were lysed and the resulting cell extract was subjected to
immunoprecipitation with anti-ﬂag antibodies. Resulting pull-
downs were immunoblotted with PSF and ﬂag antibodies.
As shown in Fig. 1A, PSF was substantially enriched in ﬂag-MS2SF by siRNA. 293T cells were transfected either with siRNA targeting PSF (siPSF) or
TK, Tat and Rev. Cells were harvested 24 h later for immunoblot analysis to assess
liced and unspliced HIV-1 RNA levels modulated by PSF. Spliced (S) and unspliced
Bromide stained agarose gel by endpoint RT-PCR on total RNA extracted from 293T
NA was not affected (b-actin mRNA) (lines 1–4, lower panel). Reactions without RT
d as control of DNA contamination in the reaction. (C) Quantitative analysis of
n siRNA treated 293T cells treated as above was analyzed by quantitative real-time
ereby siCTRL 293T treated cells in the absence of Rev were set as 1. The results of
.01). (D) Rev-dependent expression of HIV-1 Gag (p17*). Western blot analysis of
FP as indicated. Protein p17* is the product of the truncated gag gene of the vHY-
A. Kula et al. / Virology 435 (2013) 329–340332pulldowns in cells expressing HIV-1 RNA compared to control
cells conﬁrming that PSF interacts speciﬁcally with HIV-1 RNA.
To investigate the functional role of PSF in HIV-1 replication,
we measured the effect of RNAi-mediated PSF knockdown on a
full-length HIV-1 molecular clone carrying the luciferase reporter
gene in nef (pNL4.3R-E-luc). As shown in Fig. 1B, upon PSF
depletion we observed that gag expression, which is dependent
on Rev-mediated export of RRE containing RNAs, was reduced.
Conversely, the luciferase activity, which depends on the Rev-
independent nef transcript, was not affected (Fig. 1C). These
ﬁndings suggest that PSF is involved in Rev-mediated export of
RRE containing RNAs rather than transcription.
PSF impacts on Rev activity in the nucleus
In order to conﬁrm if PSF affects Rev activity we knocked down
PSF by siRNAs and looked at the viral RNA expressed from the
HIV-1 derived vector vHY-IRES-TK (Marcello and Giaretta, 1998).
This vector, that we extensively used to characterize MATR3
function, is Tat and Rev responsive and expresses a portion of
the Gag protein (p17n) that can be detected by immunoblot
(Kula et al., 2011). As shown in Fig. 2A, efﬁcient knockdown ofFig. 3. PSF knockdown affects Rev activity on unspliced HIV-1 RNA in the nucleus. (A) Q
and in the cytoplasm. Unspliced (US) viral RNA expression in siRNA-treated 293T cells w
levels were analyzed by quantitative real-time PCR on nuclear (NF) and cytoplasmic fr
fold changes, whereby siCTRL 293T treated cells transfected with were set as 1. The
signiﬁcant (po0.01 for both cases). (B) Quantitative analysis of spliced HIV-1 RNA l
conducted for spliced (S) HIV-1 RNA as described above A. No signiﬁcant decrease
fractionation and siRNA-mediated knockdown of PSF. A typical western blot of duplicate
293T cells used in (A and B) is shown. Tubulin was detected only in the cytoplasmic fr
(siCTRL) and was depleted from nuclear extracts of cells treated with the siRNA againPSF was obtained in the presence and absence of Rev. Next we
examined the levels of unspliced viral RNA by RT-PCR. As shown
in the Fig. 2B, in the presence of Rev, the level of unspliced viral
RNA is increased due to Rev activity (compare lane 3 and 4).
Interestingly, the Rev-mediated increase of unspliced HIV-1 pre-
mRNA over spliced RNA was less evident when PSF was depleted
(Fig. 2B, compare lanes 1 and 2). Quantitative real-time RT-PCR
(qRT-PCR) conﬁrmed that, while depletion of PSF did not affect
the steady-state levels of unspliced RNAs, it strongly affected its
Rev-mediated increase (Fig. 2C). Furthermore, we demonstrated
that the level of p17 protein, which is a product of the truncated
gag gene expressed from unspliced Rev-dependent transcripts of
vHY-IRES-TK, was impaired upon PSF depletion (Fig. 2D). These
ﬁndings demonstrate that PSF impacts on viral unspliced RNA and
Rev-activity. However, PSF could act either by modulating the
levels of viral RNA in the nucleus or by affecting Rev-mediated
nuclear export. To address this point we fractionated the cells and
measured the levels of viral transcripts in the nucleus and in the
cytoplasm. As shown in Fig. 3A, the levels of both the nuclear and
the cytoplasmic unspliced HIV-1 RNAs signiﬁcantly decreased
when PSF was depleted. To the contrary, the nuclear and the
cytoplasmic Rev-independent spliced HIV-1 RNA did not differuantitative analysis of unspliced HIV-1 RNA levels modulated by PSF in the nucleus
as assessed after transfection with vHY-IRES-TK, Tat and Rev-EGFP. Unspliced RNA
actions (CF). Data were normalized to b-actin mRNA expression and presented as
results of three independent experiments are shown7SD. The inhibitions were
evels modulated by PSF in the nucleus and the cytoplasm. The experiment was
was observed (p40.05 for both cases). (C) Control of nuclear and cytoplasmic
protein extracts from the nuclear or the cytoplasmic fraction of the siRNA-treated
actions while PSF was detected only in the nucleus of control siRNA-treated cells
st PSF (siPSF).
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cytoplasmic fractionation and RNAi mediated knockdown of PSF a
routine immunoblot was performed for Tubulin and PSF itself as
shown in Fig. 3C.
Previously by a similar approach it was found that MATR3
impacts selectively on the cytoplasmic levels of unspliced
viral RNA pointing to the involvement at the step of Rev-
mediated export (Kula et al., 2011; Yedavalli and Jeang, 2011a).
Here instead we observed that PSF impacts on both pools of Rev-
dependent transcripts (Fig. 3A). This result is consistent with
the interpretation that PSF may be involved in maintaining the
levels of nuclear unspliced viral RNA upstream of the activity of
MATR3 and Rev.
Association of PSF with MATR3, Rev and viral RNA
Since both PSF and MATR3 bind viral RNA and were shown to
form a complex by others we wished to explore their reciprocalFig. 4. Association of PSF with MATR3 and Rev. (A) Immunoprecipitation (IP) of GFP-ta
Tat and the various GFP-constructs (GFP is a negative control) with or without Rev wer
blotting. (B) MATR3 co-immunoprecipitation with PSF does not require RNA. Whole cell
either anti-MATR3 antibodies or with anti-IgG (mock) and the proteins were detected
nuclease treatment. (C) PSF co-immunoprecipitation with Rev requires nucleic acid. W
subjected to IP with anti-PSF antibodies or with anti-IgG (mock). The IP were subjecteinteractions in the presence of Rev. To this end we immuno-
precipitated GFP-tagged MATR3 and PSF as shown in Fig. 4A.
We found that MATR3 and PSF interact both in the presence and
absence of the Rev protein. This observation was conﬁrmed by
pulling down the endogenous MATR3 that we found associated
with PSF (Fig. 4B). Moreover we observed that PSF interacts with
MATR3 in an RNA independent manner being resistant to nucle-
ase treatment as shown in Fig. 4B. We can conclude that MATR3
and PSF form a complex through a protein–protein interaction.
Next we asked whether the Rev protein could interact with
PSF. To answer this question we set to immunoprecipitate PSF
and we found that it binds Rev through RNA since less Rev could
be observed in the presence of nuclease treatment (Fig. 4C). We
can conclude that the interaction of PSF with the viral Rev protein
is RNA-mediated as it has been previously observed for MATR3
(Kula et al., 2011; Yedavalli and Jeang, 2011a).
PSF and MATR3 have been shown to be part of a complex
that retain hyperedited dsRNA in the nucleus (Zhang andgged MATR3 and PSF. Whole cell lysates from 293T cells expressing vHY-IRES-TK,
e subjected to IP with anti-GFP antibodies and proteins were detected by western
lysates from 293T cells expressing vHY-IRES-TK and Tat were subjected to IP with
by Western blot. PSF could be detected on IPs and the interaction persisted after
hole cell lysates from 293T cells expressing vHY-IRES-TK, Tat, and Rev-GFP were
d to treatment with nuclease and the proteins were detected by western blotting.
Fig. 5. Sub-nuclear localization of PSF, MATR3 and Rev. (A) Localization of PSF on HIV-1 RNA at the transcription site. U2OS cell clones expressing Cherry-MS2nls and GFP-
tagged PSF were activated by Tat. In both cell lines expressing HIV-1 RNA, GFP-PSF was found associated with the transcription site marked by the accumulation of MS2
(rows a and b, white arrow). Control U2OS cell instead did not show any enrichment of GFP-PSF at the site of irrelevant RNA transcription (row c). Localization of
endogenous PSF is also shown for both cell lines (rows d and e). (B) Lack of co-localization of MATR3 to nascent HIV-1 RNAs. U2OS cells were treated as described
above. MATR3-GFP was nuclear but did not show any enrichment at HIV-1 transcription sites (rows a and b). Similarly, endogenous MATR3 showed the same pattern
(rows c and d). C) Localization of Rev on HIV-1 RNA at the transcription site. U2OS cell clones expressing Cherry-MS2nls and GFP-tagged Rev were activated by Tat. In both
cell lines expressing HIV-1 RNA, Rev-EGFP was found associated with the transcription site marked by the accumulation of MS2 (rows a and b, white arrow).
A. Kula et al. / Virology 435 (2013) 329–340334Carmichael, 2001). However, we could not ﬁnd evidence of
substantial A to I hyperediting of HIV-1 RNA (see SI Results and
Table S2). Hence, the involvement of MATR3 and PSF in nuclear
retention of unspliced HIV-1 RNA and Rev activity is independent
of hyperediting.
Sub-nuclear distribution of PSF, MATR3, Rev and the HIV-1
transcription site
A great advantage of the MS2-tagging method for RNA visuali-
zation is that it discriminates between factors that are associating
with nascent RNA or involved at later stages of RNA processing.
For example, RNA polymerase II, Tat, CDK9 and Cyclin T1 were all
previously found at the site of HIV-1 active transcription, as
expected (Boireau et al., 2007; De Marco et al., 2008, 2010;
Maiuri et al., 2011b; Molle et al., 2007). In order to explore the
localization of PSF we exploited a GFP-tagged version of the
protein that was expressed in U2OS HIVintro or U2OS HIVexo
together with Tat and Cherry-MS2nls. Both factors were found
spatially associated with HIV-1 transcription (Fig. 5A, rows a
and b). PSF also localized to sub-nuclear structures consistent
with paraspeckles, a site of PSF accumulation already described
(Fig. S2A) (Prasanth et al., 2005; Sasaki et al., 2009). However,
unspliced HIV-1 RNA co-localized with PSF only at the site oftranscription and not in paraspeckles (Fig. S2B). Also endogenous
PSF co-localized with the HIV-1 transcription site, ruling out
overexpression artifacts (Fig. 5A rows d and e). A control cell line
carrying an integrated CMV-driven construct expressing RNA
with the same MS2 repeats (U2OS_CMV24MS2) did not show
any co-localization with PSF, pointing to a speciﬁc role of these
factors in HIV-1 RNA processing (Fig. 5A row c).
Next we explored the localization of MATR3. GFP-tagged
MATR3 showed a nuclear localization with a punctuate appear-
ance, but was never found associated with nascent HIV-1 RNA
(Fig. 5B, rows a and b). The same was true using an antibody
against the endogenous MATR3 protein (Fig. 5B rows c and d).
Finally we investigated the localization of Rev using a
Rev-EGFP construct that was shown to be functional in U2OS and
HeLa cells (Supplementary Fig. S3A and B, respectively). Rev is a
shuttling protein that appears predominantly nuclear at steady
state in HeLa cells (Supplementary Fig. S3C) and predominantly
cytoplasmic and nucleolar in U2OS cells (Fig. 5C). Interestingly,
Rev was found associated with the site of HIV-1 transcription in
both cell lines (Fig. 5C, rows a and b; Supplementary Fig. S3C).
In other terms, unspliced RRE-containing HIV-1 RNA is available
for Rev-mediated export at the site of transcription.
Collectively, these data indicate that PSF and Rev bind nascent
viral transcripts at the site of HIV-1 transcription while MATR3
Fig. 6. Sub-nuclear localization of factors and RNA. (A) Biochemical fractionation of cells. 293T cells expressing vHY-IRES-TK, Tat and Rev-EGFP were subjected to a
biochemical fractionation protocol to separate the cytoplasmic (S1), the nucleoplasmic (S2) and the nuclear insoluble (P2) fractions. Each fraction was immunoblotted to
the factors indicated (panels a–i). The stained SDS PAGE was used as loading control (bottom panel j). (B) Association of viral RNAs with different fractions. RNA extracted
from the same fractions of the experiment above was reverse transcribed and ampliﬁed with primers for the unspliced HIV-1 RNA (upper panel) and for b-actin mRNA
(lower panel). Controls for genomic contamination are also shown (-RT).
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of transcription.
Sub-nuclear fractionation of PSF, MATR3 and Rev
In order to explore further the sub-nuclear distribution of
proteins and RNA we established a protocol to separate nuclear
soluble and insoluble fractions after digestion with DNase
(Supplementary Fig. S4). As shown in Fig. 6A panels a and b
respectively, MATR3 behaves like a typical matrix protein
whereas PSF is found in both the insoluble (P2) and soluble (S2)
fractions similar to chromatin-bound proteins like histones
(Fig. 6A, panel i). Rev instead is found in the cytoplasm (S1) and
in the soluble nuclear fraction (S2), but much less in the insoluble
nuclear fraction (P2) (Fig. 6A, panel c). When we explored the
localization of unspliced HIV RNA we found it associated with the
insoluble fraction (Fig. 6B, top panels). Rev induced its appearance
in the soluble nuclear fraction as well as in the cytoplasm (Fig. 6B,
top panels) in agreement with the production of p17 (Fig. 6A,
panel d). Control b-actin RNA was found in the insoluble fraction,
as well as in the nucleoplasm and the cytoplasm, both with or
without Rev (Fig. 6B, bottom panels).
The insoluble fraction is rather heterogeneous and includes
matrix components, like lamins (Fig. 6A, panel f), as well as
elongating RNAPII (Fig. 6A, panels g and h) (Mortillaro et al.,
1996). Therefore, we reasoned that spatially and functionally
deﬁned compartments are present in the nuclear insoluble frac-
tion but we could not distinguish them with the current protocol.
In order to distinguish the MATR3 compartment from the rest of
the insoluble fraction we set to immunoprecipitate HIV-1 RNA
using GFP-tagged proteins. As control for the immunoprecipita-
tion we used Lamin A that is present in the insoluble fraction
(Fig. 6A panel f), but may not be involved in HIV-1 RNA proces-
sing. As shown in Fig. 7A, GFP-PSF, MATR3-GFP and control
LaminA-GFP could be immunoprecipitated from the P2
fraction both in the presence or absence of Rev. Unspliced HIV
RNA remains associated only with MATR3-GFP and not withGFP-tagged Lamin A or PSF (Fig. 7B, compare with pulldown of
the irrelevant b-actin RNA). We conclude that unspliced HIV-1
pre-mRNA is found associated with MATR3 in the insoluble
nuclear matrix. Interestingly, Rev expression did not deplete
RNA from MATR3 pointing to the maintenance of the MATR3
pathway also in the presence of Rev.Discussion
Once integrated into chromatin, the HIV-1 provirus occupies a
spatially deﬁned position within the nucleus (Dieudonne et al.,
2009; Marcello et al., 2010). The single pre-mRNA that is tran-
scribed at this site generates several species of mRNAs and the
viral genome that are exported to the cytoplasm for translation
and packaging, respectively. The viral Rev protein binds the viral
RNA through RRE to permit nuclear export of incompletely
spliced RNAs and unspliced genomic RNA. Several nuclear cofac-
tors are believed to take part in this journey from the site of
transcription to the nuclear pore. We have previously developed
an unbiased proteomic screen to identify proteins that assemble
speciﬁcally on viral RNA in the context of viral transcription in the
nucleus. MATR3, found in this screen, has been already implicated
as a cofactor of Rev activity. In this work we extended this
observation further providing evidence of the involvement of
PSF, another nuclear protein that copuriﬁed with viral RNA. Like
for MATR3, we did not observe an effect of PSF siRNA-mediated
knockdown on transcription. Instead, PSF depletion affected Rev
mediated levels of HIV-1 pre-mRNA, which is consistent with a
role for PSF in stabilizing pre-mRNA. Differently from MATR3 that
affects the ability of Rev to export RNA, PSF seemed to act
upstream of MATR3, directly on the RNA pools available for Rev
in the nucleus. We further demonstrated that MATR3 and PSF
could interact at the protein level and both bound viral RNA, but
not directly Rev.
PSF and MATR3 were previously shown to retain A to I
hyperedited RNA in the nucleus (Zhang and Carmichael, 2001).
Fig. 7. Deﬁnition of a MATR3 sub-nuclear compartment. (A) IP of transfected
MATR3-GFP, GFP-PSF and LaminA-GFP from the nuclear insoluble fraction. 293T
cells expressing vHY-IRES-TK, Tat and the various constructs with or without Rev
as indicated were subjected to biochemical fractionation. The P2 fraction was IP
with anti-GFP antibodies and proteins detected by immunoblotting. (B) IP of RNA
associated with MATR3 from the nuclear insoluble fraction. IP material from cells
treated as above was subjected to reverse-transcription and ampliﬁed with
primers for the unspliced HIV-1 RNA and for b-actin. Controls for RNA ampliﬁca-
tion are also shown (-RT).
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edited in selected regions for double-stranded RNA that were
previously shown to be potential targets for A to I editing like TAR
(Sharmeen et al., 1991) or RRE (Phuphuakrat et al., 2008). Only
background modiﬁcation levels were found at these positions, as
also observed by others (Bourara et al., 2000). Therefore, we could
conclude that the activity of MATR3 and PSF on unspliced HIV-1
RNA was independent of RNA hyperediting.
In order to understand at which step of the Rev pathway these
factors are involved we explored their sub-nuclear localization
with respect to the site of HIV-1 transcription. We found that
while PSF associates with the pre-mRNA at site of HIV-1 RNA
biogenesis, MATR3 seems to act on viral RNA in the nucleoplasm.
Additionally, we explored the localization of the viral Rev protein
and we observed that it also bound nascent HIV pre-mRNA at the
transcription site. This is an important ﬁnding since so far the
only indirect demonstration of Rev acting co-transcriptionally
comes from early studies on the transactivation potential of
Tat-Rev hybrids tethered to TAR-less constructs through associa-
tion with the RRE (Luo et al., 1993; Southgate et al., 1990).
We conﬁrmed these ﬁnding by biochemical fractionation of
the cell to discriminate insoluble from soluble nuclear proteins
and proteins associated with chromatin. PSF was found both in
the soluble fraction, where it could bind viral RNA and consistent
with its localization at the transcription site, and in the nuclearinsoluble fraction where it was unable to associate with viral
RNA. MATR3 instead, was found predominantly in the nuclear
insoluble fraction associated with viral RNA. Rev was detected in
the cytoplasm as well as in the nuclear soluble fraction, again
consistent with its localization. Unspliced HIV-1 RNA was present
mostly in the insoluble nuclear fraction associated with MATR3,
in the absence of Rev, and appeared in the soluble and cyto-
plasmic fraction when Rev was expressed. However, Rev expres-
sion did not appear to deplete RNA from the MATR3 associated
fraction. Interestingly, Rev function requires continued synthesis
of HIV-1 pre-mRNA (Iacampo and Cochrane, 1996), an observa-
tion consistent with the localization of Rev at the transcription
site. Therefore, rather than forming a nuclear storage compart-
ment for viral pre-mRNA where Rev would act, as it has been
previously proposed (Berthold and Maldarelli, 1996; Najera et al.,
1999; Schwartz et al., 1992), HIV-1 pre-mRNA appears to be
associated with Rev at the site of transcription from where it is
further exported towards MATR3. The exact role of MATR3
remains elusive. It has been shown that MATR3 is highly proximal
to nascent RNA and RNAPII sites but with no direct overlap
(Malyavantham et al., 2008). This led to the proposal that MATR3
is part of ‘functional neighborhoods’ where genomic functions are
concentrated and may potentially be directly involved in the
regulation of molecular processes. MATR3 was also copuriﬁed
with nuclear pore components leading to the hypothesis that it
may bridge transcription to export of RNA, possibly in concert
with the RNA helicase DDX3X and CRM1. Giving that the provirus
was found in proximity to the nuclear periphery it is possible to
think a spatially organized perinuclear compartment where
nascent viral RNA poised for export by PSF and Rev is transferred
to MATR3 for immediate nuclear export.
PSF is a multifunctional RNA binding protein that has been
implicated in several steps of the gene expression and DNA repair
pathways (Shav-Tal and Zipori, 2002). PSF interacts with splicing
factors and the carboxyterminal domain of RNAPI. It has been
shown that PSF controls alternative splicing as well as transcrip-
tion of several genes including viral transcription in the case of
inﬂuenza (Landeras-Bueno et al., 2011). PSF has also been identi-
ﬁed as a cellular factor binding RNA of hepatitis delta virus as well
as HIV-1 RNA (Greco-Stewart et al., 2006; Kula et al., 2011;
Zolotukhin et al., 2003). PSF can be found in the insoluble fraction
of the nucleus, consistent both with its role in the retention
of A4 I hyperedited RNA and with its association to non-coding
RNAs in paraspeckles. In this work we propose that, in the
absence of Rev, PSF binds nascent HIV pre-mRNA at the site of
viral transcription, which is then released to MATR3 in the
insoluble fraction of the nucleus (Fig. 8A). This pathway of RRE-
containing unspliced viral RNAs maintenance is targeted by the
Rev protein. Rev binds the nascent viral pre-mRNA to redirect it to
nuclear export through a still poorly characterized mechanism
that involves also MATR3 (Kula et al., 2011; Yedavalli and Jeang,
2011a) (Fig. 8B). In conclusion our current work proposes a highly
dynamic interplay between viral and cellular factors that deter-
mines the fate of newly transcribed HIV-1 pre-mRNAs. This novel
pathway would target a portion of the viral pre-mRNA to a
nuclear retention PSF/MATR3 pathway that is hijacked by Rev
for nuclear export.Materials and methods
Cells and plasmids
Cells were cultivated at 37 1C in Dulbecco’s Modiﬁed Eagle
Medium (DMEM) containing 10% FCS and antibiotics. U2OS_
HIVexo and U2OS_HIVintro cells were obtained as described
Fig. 8. A schematic view of the regulation of HIV-1 pre-mRNA by PSF and MATR3. The drawing represents our working model. At the site of HIV-1 transcription, a certain
proportion of HIV-1 pre-mRNA is bound by PSF and diverted towards MATR3 compartments in the insoluble fraction of the nucleus (A). PSF interacts with MATR3 but is
released from the insoluble fraction (diagonal pattern). Rev hijacks this pathway by binding nascent HIV-1 RNA primed by PSF and requires MATR3 for nuclear export (B).
A. Kula et al. / Virology 435 (2013) 329–340 337previously (Boireau et al., 2007; Kula et al., 2011). U2OS_CMV_
24MS2 were generated by transfecting plasmid CMV_24MS2
(see below) into U2OS cells together with pTK-Hygro and indivi-
dual clones selected in 132 mg/ml hygromycin.
Plasmids encoding tagged versions of HIV-1 Tat, MATR3 and
MS2 were previously described (Boireau et al., 2007; De Marco
et al., 2008; Kula et al., 2011; Maiuri et al., 2011b; Marcello et al.,
2001). Plasmid pCMV-Flag-MATR3 was obtained from Yosef
Shiloh and Maayan Salton (Tel Aviv University, Israel). Plasmids
encoding for GFP-PSF was obtained from Barbara Felber (National
Cancer Institute, Frederick, USA). Plasmid Rev-EGFP was obtained
from Dirk Daelemans (Rega Institute, Katholieke Universiteit
Leuven, Belgium). Plasmid pSV-Rev was obtained from Joseph
Sodroski (Dana Farber Cancer Institute, Boston, USA). Plasmid
pDM128 was a generous gift from Thomas Hope (Northwestern
University, Chicago, USA). The HIV-1 molecular clone pNL4.3R-
E-luc was kindly provided by Nathaniel Landau (New York
University, USA). Lentiviral vector vHY-IRES-TK was described
in (Marcello and Giaretta, 1998). Plasmid CMV_24MS2 was
obtained by cloning an array of 24MS2 binding sites into pCI-
neo (Promega). U2OS_CMV_24MS2 cells were obtained as
described above.
Antibodies, western blot and immunoprecipitations
Western blot and immunoﬂuorescence were performed with
the following antibodies: PSF, B92 (Sigma, P2860, 1:1000); MATR3
(Aviva Systems Biology, ARP40922_T100 for immunoﬂuorescence1:1000; Bethyl Laboratories A300-590A for Western blot 1:10000);
p17 (NIH AIDS Reference Reagents Program, 1:1000); MCM3 (N-19)
(Santa Cruz, sc-9850 1:500); Lamin A/C (N-18) (Santa Cruz, sc-6215,
1:1000); RNAPII (N-20) (Santa Cruz, sc-899 1:200); phospho-Ser2
RNAPII (H5) (Covance, MMS-129R, 1:500); histone H3 (Upstate,
06–755, 1:300); GFP (Roche, 11814460001, 1:1000); ﬂag (Sigma,
F1804, 1:1000); a-tubulin (Sigma, T5168, 1:10000); b-actin -HRP
(Sigma, AC-15, 1:10000); PSPC1 (Santa Cruz, sc-374181, for immu-
noﬂuorescence 1:200).
Immuoprecipitations (IPs) were performed as described pre-
viously (Marcello et al., 2003) using the MATR3 antibody (Abcam,
70336), PSF antibody (Abcam, ab99357), and GFP antibody
(Clontech, 632376). Brieﬂy, 293 T cells were lysed with RIPA
buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1% NP-40, 0.1% SDS,
1.5 mM MgCl2) and the cellular extracts were incubated for
4 hours with the antibody coupled to A/G PLUS agarose beads
(Santa Cruz, sc-2003) at 4 1C under rotation. After incubation of
beads with the indicated antibodies, IPs were washed six times in
RIPA buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1% NP-40, 0.1%
SDS, 1.5 mM MgCl2) supplemented with 0.1 mg/ml dextran and
0.2 mg/ml heparin. For nuclease treatment, IPs were incubated
with 40U of benzonase (Sigma, E1014) for 45 min at 4 1C. After
digestion, IPs were washed four times with RIPA buffer and the
proteins were eluted with 2x Laemmli buffer for SDS-PAGE.
Immunoprecipitation using the ﬂag antibody was performed
as described previously (Kula et al., 2011). Brieﬂy U2OS stable
cells lines were washed in cold PBS and lysed in RIPA buffer
(50 mM Tris-Cl; pH 7.5, 1% NP-40, 0.05% SDS, 150 mM NaCl)
A. Kula et al. / Virology 435 (2013) 329–340338plus the RNase inhibitor (Ribonucleoside Vanadyl Complex RVC,
Biolabs S1402S) and a protease inhibitor cocktail (Roche,
11836170001). After 15 min at 4 1C the monolayer was scraped
off and centrifuged at high speed. Lysates were incubated with
anti-ﬂag M2 beads (Sigma, A2220) in the presence of tRNA
(0.1 mg/ml) with rotation for 3 hours. The beads were collected
at 4000 rpm and were washed six times in RIPA buffer containing
300 mM NaCl. The proteins were eluted with 2x Laemmli buffer
for SDS-PAGE.
siRNA-mediated knockdown
siRNAs were obtained from Dharmacon: SFPQ siGENOME
SmartPool (GAAGAAGCCUUUAGCCAAU,GGCAAAGGAUUCGGAUUUA,
GAACAAAUGAGGCGCCAAA, GGGAAAGAGACAUGCGAAU), siGEN-
OME Non-Targeting siRNA Pool #1. Pools of siRNA oligonucleo-
tides were introduced into 293T cells or HeLa cells using
HiPerFect Transfection Reagent (Qiagen) according to manufac-
turer’s instructions. After 48 h the efﬁciency of the knockdown
was analyzed at the protein level by Western blot.
Nuclear and cytoplasmic fraction preparation, biochemical
preparation of insoluble nuclear fraction
Nuclear and cytoplasmic fractions were obtained as described
(Kula et al., 2011). 293T cells were washed with cold PBS and
resuspended in hypotonic buffer A: 20 mM Tris HCl [pH 7.5],
10 mM NaCl, 3 mM MgCl2, 10% glycerol and the protease inhibi-
tors cocktail (Roche). After 1 min NP-40 was added at 0.1% v/v
ﬁnal concentration for 5 min and cytoplasmic fraction was col-
lected by centrifugation at 4000 rpm for 5 min at þ4 1C. The
pellet was washed with buffer A and the nuclei were collected by
centrifugation. Further, the cytoplasmic and nuclear fractions
were subjected to RNA extraction procedure.
To isolate the cytoplasmic, nuclear soluble and nuclear inso-
luble fractions we followed the protocol of He and Penman
(He et al., 1990) with minor modiﬁcations as outlined in Fig. S2.
Transfected 293T cells were resuspended in CSK buffer: 10 mM
PIPES pH 6.8, 10 mM NaCl, 3 mM MgCl2, 0.3 M sucrose, 0.5%
Triton X-100, 1 mM DTT, 0.1 mM phenylmethylsulfonyl ﬂuoride
(PMSF), 10 mM Ribonucleoside-Vanadyl Complex (RVC, Sigma)
and protease inhibitors (Roche) and the cells were incubated for
10 min on ice. Nuclei were collected by low-speed centrifugation
at 4 1C. The supernatant was further clariﬁed by high-speed
centrifugation at 4 1C to remove cell debris and insoluble aggre-
gates (S1). Nuclei were incubated in buffer CSK with protease and
RNA inhibitors and 100U of RNase-free DNase I (Fermentas). After
15 min at 37 1C, ammonium sulfate was added from a 4 M stock
to a ﬁnal concentration of 0.25 M. The sample were rotated at 4 1C
for 5 min and centrifuged. The supernatant or chromatin fraction
(S2) and the pellet (P2) were further collected. All fractions
(S1, S2, and P2) were either lysed in 1x Laemmli buffer for
Western blot or subjected to RNA extraction.
RT-PCR and qPCR
For RT-PCR and Quantitative Real- Time PCR (qPCR) Analysis
the RNA was extracted from total cell extracts, nuclear, or
cytoplasmic fractions using Isol-RNA (Invitrogen) according
to manufacturer’s protocol. RNA was treated with DNase I
(Invitrogen) to remove genomic DNA contamination and used
as a template to synthesize cDNA using random hexamers and
M-MLV reverse transcriptase (Invitrogen) according to the man-
ufacturer’s protocol. Endpoint RT PCR (35 cycles, annealing
temperature 58 1C) was conducted with primers AþBþC
described in Table S1. Real-time PCR ampliﬁcation was conductedin the presence of KAPA SYBR FAST Bio-Rad Readymix (KAPA
Biosystems) and monitored on C1000 Thermal Cycler (Bio-Rad).
Speciﬁc primers AþB (unspliced) and AþC (spliced) are shown in
Table S1. The viral RNA abundance was calculated relative
to the b-actin mRNA expression and shown as fold change in
comparison with control samples. Results were expressed as
mean plus or minus SD. The two-tailed student-T test conﬁrmed
signiﬁcant expression changes in the results.
Chloramphenicol acetyltransferase (CAT) and luciferase assays
293T cells were transfected with the pDM128 plasmid or HeLa
cells with the pNL4.3R-E-luc HIV-1 molecular clone. 24 h later
cells were lysed and the levels of CAT or luciferase were measured
by the CAT ELISA (Roche) or the luciferase assay (Promega),
respectively, as directed by manufacturers. For normalization,
total protein concentration in each extract was determined with a
Bio-Rad protein assay kit.
Fluorescence microscopy
Cells were plated on glass, transiently transfected with the
various plasmids and kept for 24 h at 37 1C. After ﬁxation with 4%
paraformaldehyde (PFA) and permeabilization with 0.1% Triton
X-100 the localization of ﬂuorescent proteins was visualized
directly in mounting medium or incubated with the antibodies
as described elsewhere (De Marco et al., 2008, 2010; Miorin et al.,
2008). Fluorescent images of ﬁxed cells were captured on a Zeiss
LSM 510 META confocal microscope (Carl Zeiss Microimaging,
Inc.) with a 63x NA 1.4 Plan-Apochromat oil objective. The
pinhole of the microscope was adjusted to get an optical slice of
less than 1.0 mm for any wavelength acquired.Acknowledgments
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